FDA Inspection 1001716 — Samir Arora, MD

Samir Arora, MD — FEI 3013123560

The FDA completed an inspection of Samir Arora, MD on Feb 17, 2017 in Grove City, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 17, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Grove City, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.